Benin vs Botswana: Access to anti-retroviral drugs, female
Benin
98.0%
in 2024
Botswana
98.0%
in 2024
Benin rank
1st
Botswana rank
1st
Access to anti-retroviral drugs, female over time
- Benin
- Botswana
How they compare
Benin currently reports 98.0% against 98.0% in Botswana, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Botswana ahead.
Benin ranks 1st and Botswana ranks 1st of 141 countries.
Botswana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Benin | Botswana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.5% | 17.1% | 11.6% | Botswana |
| 2010s | 50.4% | 73.0% | 22.6% | Botswana |
| 2020s | 93.4% | 96.4% | 3.0% | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Benin or Botswana?
- Benin, at 98.0% against 98.0% in Botswana as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Benin and Botswana?
- 0.0%, with Benin ahead.
- How many years of comparable data are there for Benin and Botswana?
- 25 years are reported by both, from 2000 to 2024.
- How do Benin and Botswana rank globally for access to anti-retroviral drugs, female?
- Benin ranks 1st and Botswana ranks 1st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.